BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Sirolimus for Injection (Albumin-bound) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Sirolimus for Injection (Albumin-bound)\,
  from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07684287-9069@assetmemo.bio
DTSTAMP:20261121T011044Z
DTSTART;VALUE=DATE:20271130
DTEND;VALUE=DATE:20271201
SUMMARY:Sirolimus for Injection (Albumin-bound): Phase 2 readout est. (NCT0
 7684287)
DESCRIPTION:Sirolimus for Injection (Albumin-bound)\, phase 2.\nStudy: A Ph
 ase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Pr
 ogressive or Symptomatic Epithelioid Hemangioendothelioma\nEstimated prima
 ry completion: 30 November 2027. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/sirolimus-for-injection-albumin-bound#upcoming-events\nRegistr
 y record: https://clinicaltrials.gov/study/NCT07684287
URL:https://assetmemo.bio/drug/sirolimus-for-injection-albumin-bound#upcomi
 ng-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
